Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2025-05-15 00:00:00 ET · period of report 2025-05-13 · accession 0000950170-25-071961 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-05-15 | 2025-05-13 | SRPT | Barry Richard | Dir | M - OptEx | $19.23 | +20.2K | 2.95M | +0.7% | +$389.4K |
| DM | 2025-05-15 | 2025-05-13 | SRPT | Barry Richard | Dir | M - OptEx | $0.00 | -20.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-13 | M | A | 9,746 | $25.18 | 2,943,817 | D | — | — | |
| 2 | Common | Common Stock | 2025-05-13 | M | A | 10,500 | $13.71 | 2,954,317 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2025-05-13 | M | D | 9,746 | $0.00 | 0 | D | $25.18 · 2016-06-02 to 2025-06-02 | 9,746 Common Stock | |
| 4 | Derivative | Stock Option (right to buy) | 2025-05-13 | M | D | 10,500 | $0.00 | 0 | D | $13.71 · 2017-02-28 to 2026-02-28 | 10,500 Common Stock |